Abstract
Background: Volatile organic compounds (VOCs) are small molecular mass substances, which exhibit high-vapor pressures, low boiling points, and lipophilic character. VOCs are produced by all organisms including eukaryotic microbes like yeast, whose volatile metabolites are for centuries exploited for examples as flavors in bread, beer, and wine. Notably, while the applications of VOCs are many, the knowledge on their biochemical synthesis is still limited.
Objective: We review here the current information of yeast volatile metabolites and techniques to further explore the VOC landscape made possible by improvements of the analytical possibilities, regarding sampling frequency, identification, and quantification and the development to computationally interpret (high-throughput) data. Especially possibilities for online and even real-time analysis should trigger new experimental approaches that elucidate the biochemistry as well as the regulation of VOC synthesis. Baker’s yeast is here the organism of choice as the genetic inventory can be linked to VOC formation and with this in hand improved applications can be envisaged. The physical, chemical or biological properties make many VOCs interesting targets for different industrial sectors while their natural function as semiochemicals or in defense mechanisms can be exploited to engineer synthetic microbial communities or to develop new antibiotics.
Conclusion: VOCs produced by microbes including yeast are a chemical diverse group of compounds with highly different applications. The new analytical techniques briefly summarized here will enable the use of VOCs in even broader applications including human health monitoring and bioprocess control. We envisage a bright future for VOC research and for the resulting applications
Keywords: Gas chromatography, ion mobility spectrometry, metabolic pathway inference, metabolism, Saccharomyces cerevisiae, VOC, volatile organic compounds, yeast.
Graphical Abstract
Current Metabolomics
Title:Exploration and Exploitation of the Yeast Volatilome
Volume: 5 Issue: 2
Author(s): Birgitta E. Ebert*, Christoph Halbfeld and Lars M. Blank
Affiliation:
- Institute of Applied Microbiology, Aachen Biology and Biotechnology, RWTH Aachen University, 52074 Aachen,Germany
Keywords: Gas chromatography, ion mobility spectrometry, metabolic pathway inference, metabolism, Saccharomyces cerevisiae, VOC, volatile organic compounds, yeast.
Abstract: Background: Volatile organic compounds (VOCs) are small molecular mass substances, which exhibit high-vapor pressures, low boiling points, and lipophilic character. VOCs are produced by all organisms including eukaryotic microbes like yeast, whose volatile metabolites are for centuries exploited for examples as flavors in bread, beer, and wine. Notably, while the applications of VOCs are many, the knowledge on their biochemical synthesis is still limited.
Objective: We review here the current information of yeast volatile metabolites and techniques to further explore the VOC landscape made possible by improvements of the analytical possibilities, regarding sampling frequency, identification, and quantification and the development to computationally interpret (high-throughput) data. Especially possibilities for online and even real-time analysis should trigger new experimental approaches that elucidate the biochemistry as well as the regulation of VOC synthesis. Baker’s yeast is here the organism of choice as the genetic inventory can be linked to VOC formation and with this in hand improved applications can be envisaged. The physical, chemical or biological properties make many VOCs interesting targets for different industrial sectors while their natural function as semiochemicals or in defense mechanisms can be exploited to engineer synthetic microbial communities or to develop new antibiotics.
Conclusion: VOCs produced by microbes including yeast are a chemical diverse group of compounds with highly different applications. The new analytical techniques briefly summarized here will enable the use of VOCs in even broader applications including human health monitoring and bioprocess control. We envisage a bright future for VOC research and for the resulting applications
Export Options
About this article
Cite this article as:
E. Ebert Birgitta*, Halbfeld Christoph and M. Blank Lars, Exploration and Exploitation of the Yeast Volatilome, Current Metabolomics 2017; 5 (2) . https://dx.doi.org/10.2174/2213235X04666160818151119
DOI https://dx.doi.org/10.2174/2213235X04666160818151119 |
Print ISSN 2213-235X |
Publisher Name Bentham Science Publisher |
Online ISSN 2213-2368 |
Related Articles
-
Modifications of Cell Signalling and Redox Balance by Targeting Protein Acetylation Using Natural and Engineered Molecules: Implications in Cancer Therapy
Current Topics in Medicinal Chemistry Recent Advances in the New Generation Taxane Anticancer Agents
Medicinal Chemistry Tangy Scent in Toona sinensis (Meliaceae) Leaflets: Isolation, Functional Characterization, and Regulation of TsTPS1 and TsTPS2, Two Key Terpene Synthase Genes in the Biosynthesis of the Scent Compound
Current Pharmaceutical Biotechnology Mogroside V Inhibits Hyperglycemia-induced Lung Cancer Cells Metastasis through Reversing EMT and Damaging Cytoskeleton
Current Cancer Drug Targets Current State of the Art of New Tubulin Inhibitors in the Clinic
Current Clinical Pharmacology Passive and Active Tumour Targeting with Nanocarriers
Current Drug Discovery Technologies Targeting the Mitochondrial Electron Transport Chain Complexes for the Induction of Apoptosis and Cancer Treatment
Current Pharmaceutical Biotechnology The Cancer Preventive Effects of Edible Mushrooms
Anti-Cancer Agents in Medicinal Chemistry 9-Hydroxyellipticine and Derivatives as Chemotherapy Agents
Mini-Reviews in Medicinal Chemistry Proteasome Inhibition as a New Therapeutic Principle in Hematological Malignancies
Current Drug Targets Lipid Rafts and Fas/CD95 Signaling in Cancer Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery Editorial from Guest Editor [Hot Topic:Vitamin D and Respiratory Health (Guest Editor: Adrian R. Martineau)]
Current Respiratory Medicine Reviews Is there a Possible Single Mediator in Modulating Neuroendocrine–thymus Interaction in Ageing?
Current Aging Science Novel Concepts in the Development of Platinum Antitumor Drugs
Current Medicinal Chemistry - Anti-Cancer Agents MUC1 Story: Great Expectations, Disappointments and the Renaissance
Current Medicinal Chemistry Current Drug Therapy for Prostate Cancer: An Overview
Current Medicinal Chemistry - Anti-Cancer Agents Metabolite Characterization of Anti-cancer Agent Gefitinib in Human Hepatocytes
Drug Metabolism Letters Bioactive Secondary Metabolites from a Thai Collection of Soil and Marine-Derived Fungi of the Genera Neosartorya and Aspergillus
Current Drug Delivery Glycosylation of Tetraspanin Tspan-1 at Four Distinct Sites Promotes Its Transition Through the Endoplasmic Reticulum
Protein & Peptide Letters MEK Inhibitors: A Therapeutic Approach to Targeting the Ras-MAP Kinase Pathway in Tumors
Current Pharmaceutical Design